Pancreatic Cancer Research

ResearcherMayo ClinicActive in the last 2 years

Stephan B. Dreyer

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-6134-2096; OpenAlex author ID A5013770499. Sources: OpenAlex.

Their work

Papers
21 (first author 1, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
89
Papers, trials and grants by year

2017: 1 paper · 2018: none · 2019: 3 papers · 2020: 4 papers · 2021: 4 papers · 2022: 2 papers · 2023: 1 paper · 2024: none · 2025: 3 papers · 2026: 3 papers

Papers 21

  1. Clonal evolutionary analysis reveals patterns of malignant transformation of Intraductal Papillary Mucinous Neoplasms of the pancreas. Co-author DOI 10.1038/s41467-026-69762-w↗
  2. Clinical and molecular landscape of surgically resected early onset pancreatic cancer. Co-author DOI 10.1093/bjs/znag032↗
  3. Morphospatial profiling of cancer-associated fibroblasts reveals architectural subtypes of pancreatic ductal adenocarcinoma Co-author DOI 10.64898/2026.02.06.704414↗
  4. Routine Imaging or Symptomatic Follow-Up After Resection of Pancreatic Adenocarcinoma. Co-author DOI 10.1001/jamasurg.2024.5024↗
  5. Sequential ATR and PARP inhibition overcomes acquired DNA damaging agent resistance in pancreatic ductal adenocarcinoma. Co-author DOI 10.1038/s41416-025-03051-z↗
  6. Improving outcomes of patients with pancreatic cancer. Co-author DOI 10.1038/s41571-025-01019-9↗
  7. The Impact of Molecular Subtyping on Pathological Staging of Pancreatic Cancer. Co-author DOI 10.1097/sla.0000000000005050↗
  8. Genomic and Molecular Analyses Identify Molecular Subtypes of Pancreatic Cancer Recurrence. Co-author DOI 10.1053/j.gastro.2021.09.022↗
  9. Exploring the Biology of Cancer-Associated Fibroblasts in Pancreatic Cancer. First author DOI 10.3390/cancers14215302↗
  10. Reshaping preoperative treatment of pancreatic cancer in the era of precision medicine. Co-author DOI 10.1016/j.annonc.2020.11.013↗
  11. Targeting DNA Damage Response and Replication Stress in Pancreatic Cancer. Co-author DOI 10.1053/j.gastro.2020.09.043↗
  12. New Insights Into Pancreatic Cancer: Notes from a Virtual Meeting. Co-author DOI 10.1053/j.gastro.2021.04.082↗
  13. ROR1 and ROR2 expression in pancreatic cancer. Co-author DOI 10.1186/s12885-021-08952-9↗
  14. HNF4A and GATA6 Loss Reveals Therapeutically Actionable Subtypes in Pancreatic Cancer. Co-author DOI 10.1016/j.celrep.2020.107625↗
  15. PRECISION-Panc: the Next Generation Therapeutic Development Platform for Pancreatic Cancer. Co-author DOI 10.1016/j.clon.2019.07.011↗
  16. Pancreatic Cancer: From Genome Discovery to PRECISION-Panc. Co-author DOI 10.1016/j.clon.2019.08.007↗
  17. Precision Oncology in Surgery: Patient Selection for Operable Pancreatic Cancer. Co-author DOI 10.1097/sla.0000000000003143↗
  18. Macrophage-Released Pyrimidines Inhibit Gemcitabine Therapy in Pancreatic Cancer. Co-author DOI 10.1016/j.cmet.2019.02.001↗
  19. Feasibility and clinical utility of endoscopic ultrasound guided biopsy of pancreatic cancer for next-generation molecular profiling. Co-author DOI 10.21037/cco.2019.04.06↗
  20. Clinical utility of molecular subtyping of pancreatic cancer Co-author DOI 10.5525/gla.thesis.74314↗
  21. Pancreatic Cancer Genomes: Implications for Clinical Management and Therapeutic Development. Co-author DOI 10.1158/1078-0432.ccr-16-2411↗

Closest collaborators

The 25 strongest of 89 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. David Kuang-Fu Chang · 12 shared papers, 2017–2026 · strength 1.80
  2. Andrew Victor Biankin · 11 shared papers, 2017–2026 · strength 1.71
  3. Fieke E. M. Froeling · 6 shared papers, 2021–2026 · strength 1.30
  4. Nigel Balfour Jamieson · 7 shared papers, 2019–2026 · strength 1.03
  5. Colin J. McKay · 6 shared papers, 2019–2026 · strength 0.90
  6. Adam S. Bryce · 3 shared papers, 2022–2026 · strength 0.73
  7. Sunil R. Hingorani · 1 shared paper, 2025 · strength 0.37
  8. Australian Pancreatic Cancer Genome Initiative · 2 shared papers, 2023–2025 · strength 0.36
  9. Alessandra Pulvirenti · 2 shared papers, 2023–2026 · strength 0.35
  10. Antonio Pea · 2 shared papers, 2023–2026 · strength 0.35
  11. Rita Teresa Lawlor · 2 shared papers, 2023–2026 · strength 0.35
  12. Aldo Scarpa · 2 shared papers, 2023–2026 · strength 0.35
  13. Roberto Salvia · 2 shared papers, 2023–2026 · strength 0.35
  14. Christian P. Pilarsky · 2 shared papers, 2020–2025 · strength 0.30
  15. Jennifer P. Morton · 3 shared papers, 2019–2021 · strength 0.29
  16. Katharine J. Herbert · 1 shared paper, 2025 · strength 0.23
  17. David K. Chang · 1 shared paper, 2026 · strength 0.22
  18. Claudio Luchini · 1 shared paper, 2026 · strength 0.22
  19. Jaswinder Singh Samra · 2 shared papers, 2020–2023 · strength 0.21
  20. Amber L. Johns · 2 shared papers, 2020–2023 · strength 0.21
  21. Anthony James Gill · 2 shared papers, 2020–2023 · strength 0.21
  22. Peter J. Bailey · 2 shared papers, 2017–2020 · strength 0.17
  23. Marina Pasca di Magliano · 2 shared papers, 2019–2021 · strength 0.16
  24. C. Ross Carter · 2 shared papers, 2019–2020 · strength 0.15
  25. Owen James Sansom · 1 shared paper, 2020 · strength 0.13

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.